Earth Science Tech, Inc. (ETST) Looking Forward to
Post# of 333
- Addressing a global epidemic through the launch of Hygee
- Partnered with communications agencies to raise brand awareness and increase visibility
- Positioned for success following a year filled with new achievements
According to the Centers for Disease Control (CDC), more than two million cases of chlamydia, gonorrhea and syphilis were reported in the United States in 2016. The majority (1.6 million) were newly-diagnosed cases of chlamydia. Young women make up nearly half of all diagnosed chlamydia cases. The CDC recommends that STD screening and timely treatment become a standard part of medical care (http://nnw.fm/CK2qo). Decreasing the stigma of talking about STDs is important in creating a culture that seeks out testing, especially for pregnant women. Left untreated, chlamydia can lead to miscarriages, premature birth or stillbirth, and it can be passed to the infant during childbirth.
Earth Science Tech, Inc. (OTCQB: ETST) is strategically positioning Hygee, a non-invasive discreet chlamydia testing kit, as the answer to this global epidemic. The company announced earlier this month (http://nnw.fm/e5Ce3) that it has partnered with communication agencies Les Fous de la Com and Priori System to build a strong online presence, create brand recognition and awareness, educate consumers and develop partnerships and associations for increased visibility on local, national and international levels.
“We are delighted to work with Earth Science in the promotion of Hygee, as it stands to improve the quality of life of women everywhere on the planet,” Priori System President Christian Dumont stated in the news release. “The goal is to bring Hygee to women everywhere, making the product and the service so well known that we can finally begin to ease the catastrophe of Chlamydia and other sexually transmitted infections.”
Nickolas S. Tabraue, chairman of ETST, believes strongly in the success of Hygee. While the company has the ability to turn the tide of the chlamydia epidemic, it will take the support of governments and the medical community to make this vision a reality. “This will work,” Tabraue noted in the release, “because we will put Hygee in the hands of the women who need it. We are going to give women control over their own testing, and their own bodies. As confident as we are in our product, that is going to take a community, not a company.”
Following a year filled with achievement, ETST is strategically positioned for success in 2019. In 2018, ETST successfully:
Became fully reporting;
Uplisted to the OTCQB Venture Market;
Improved its High Grade Full Spectrum line;
Increased sales by more than 100 percent; and
Ordered the first batch of Hygee, which is expected to launch later this month.
As members of the management team reflected on the success of 2018 (http://nnw.fm/5FyGp), they also shared their vision and excitement for the upcoming year. Overall, the feeling is one of positive excitement as distribution and presence in the marketplace increase, potential is realized and new opportunities await.
For more information, visit the company’s website at www.EarthScienceTech.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer